NCT00249366View on ClinicalTrials.gov

Treatment of Alcohol Withdrawal in Hospital Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Alcohol Withdrawal Syndrome
Interventions
DRUG

Lorazepam (drug)

Lorazepam administered orally or IV for treatment of alcohol withdrawal in hospitalized patients

DRUG

Lorazepam

Lorazepam administered orally or IV for treatment of alcohol withdrawal in hospitalized patients

Trial Locations (1)

23219

Virginia Commonwealth University Medical Center, Richmond

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Virginia Commonwealth University

OTHER

NCT00249366 - Treatment of Alcohol Withdrawal in Hospital Patients | Biotech Hunter | Biotech Hunter